Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $60 to $107.
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $60 to $107.